{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":81,"mapped":1},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P11362","source":"P11362|Fibroblast growth factor receptor 1","targets":["1AGW|CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR|X-RAY DIFFRACTION|2.4|Homo sapiens|0|PROTEIN KINASE","1CVS|CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX|X-RAY DIFFRACTION|2.8|Homo sapiens|0|GROWTH FACTOR/GROWTH FACTOR RECEPTOR","1EVT|CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)|X-RAY DIFFRACTION|2.8|Homo sapiens|0|GROWTH FACTOR/GROWTH FACTOR RECEPTOR","1FGI|CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR|X-RAY DIFFRACTION|2.5|Homo sapiens|0|PROTEIN KINASE","1FGK|CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1|X-RAY DIFFRACTION|2|Homo sapiens|0|PHOSPHOTRANSFERASE","1FQ9|CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX|X-RAY DIFFRACTION|3|Homo sapiens|0|GROWTH FACTOR/GROWTH FACTOR RECEPTOR","1XR0|Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN/GROWTH FACTOR RECEPTOR","2CR3|Solution structure of the first Ig-like domain of human fibroblast growth factor receptor 1|SOLUTION NMR||Homo sapiens|0|CYTOKINE","2FGI|CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE","3C4F|FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindole|X-RAY DIFFRACTION|2.07|Homo sapiens|0|TRANSFERASE","3DPK|cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSFERASE","3GQI|Crystal Structure of activated receptor tyrosine kinase in complex with substrates|X-RAY DIFFRACTION|2.5|Homo sapiens; Rattus norvegicus|0|Transferase/Transferase inhibitor","3GQL|Crystal Structure of activated receptor tyrosine kinase in complex with substrates|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3JS2|Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","3KRJ|cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3KRL|cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3KXX|Structure of the mutant Fibroblast Growth Factor receptor 1|X-RAY DIFFRACTION|3.2|Homo sapiens|0|TRANSFERASE","3KY2|Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE","3OJV|Crystal Structure of FGF1 complexed with the ectodomain of FGFR1c exhibiting an ordered ligand specificity-determining betaC'-betaE loop|X-RAY DIFFRACTION|2.6|Homo sapiens|0|Cytokine/Signaling Protein","3RHX|Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069|X-RAY DIFFRACTION|2.01|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3TT0|Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4F63|Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compound 1|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4F64|Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compound 6|X-RAY DIFFRACTION|2.05|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4F65|Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compound 8|X-RAY DIFFRACTION|2.26|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4NK9|Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1|X-RAY DIFFRACTION|2.57|HOMO SAPIENS|0|TRANSFERASE/TRANSFERASE INHIBITOR","4NKA|Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2|X-RAY DIFFRACTION|2.19|Homo sapiens|0|transferase/transferase inhibitor","4NKS|Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3|X-RAY DIFFRACTION|2.5|Homo sapiens|0|Transferase/transferase inhibitor","4RWI|Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo|X-RAY DIFFRACTION|2.292|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4RWJ|Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)|X-RAY DIFFRACTION|2.489|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4RWK|Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)|X-RAY DIFFRACTION|2.982|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4RWL|Crystal structure of FGFR1 (C488A, C584C) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide (E3810)|X-RAY DIFFRACTION|2.193|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4UWB|Fibroblast growth factor receptor 1 kinase in complex with JK-P5|X-RAY DIFFRACTION|2.31|HOMO SAPIENS|0|TRANSFERASE","4UWC|Fibroblast growth factor receptor 1 kinase in complex with JK-P3|X-RAY DIFFRACTION|1.96|Homo sapiens|0|TRANSFERASE","4UWY|FGFR1 Apo structure|X-RAY DIFFRACTION|2.305|HOMO SAPIENS|0|TRANSFERASE","4V01|FGFR1 in complex with ponatinib (co-crystallisation).|X-RAY DIFFRACTION|2.33|HOMO SAPIENS|0|TRANSFERASE","4V04|FGFR1 in complex with ponatinib.|X-RAY DIFFRACTION|2.12|HOMO SAPIENS|0|TRANSFERASE","4V05|FGFR1 in complex with AZD4547.|X-RAY DIFFRACTION|2.57|HOMO SAPIENS|0|TRANSFERASE","4WUN|Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) at 1.65 angstrom|X-RAY DIFFRACTION|1.65|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4ZSA|Crystal structure of FGFR1 kinase domain in complex with 7n|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5A46|FGFR1 in complex with dovitinib|X-RAY DIFFRACTION|2.63|HOMO SAPIENS|0|TRANSFERASE","5A4C|FGFR1 ligand complex|X-RAY DIFFRACTION|2.09|HOMO SAPIENS|0|TRANSFERASE","5AM6|Native FGFR1 with an inhibitor|X-RAY DIFFRACTION|1.96|HOMO SAPIENS|0|TRANSFERASE","5AM7|FGFR1 mutant with an inhibitor|X-RAY DIFFRACTION|1.957|HOMO SAPIENS|0|TRANSFERASE","5B7V|Human FGFR1 kinase in complex with CH5183284|X-RAY DIFFRACTION|2.15|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5EW8|FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693|X-RAY DIFFRACTION|1.63|Homo sapiens|0|TRANSFERASE","5FLF|DISEASE LINKED MUTATION IN FGFR|X-RAY DIFFRACTION|2.58|HOMO SAPIENS|0|TRANSFERASE","5O49|Human FGF in complex with a covalent inhibitor|X-RAY DIFFRACTION|1.91|Homo sapiens|0|TRANSFERASE","5O4A|Human FGF in complex with a covalent inhibitor|X-RAY DIFFRACTION|2.01|Homo sapiens|0|TRANSFERASE","5UQ0|FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide|X-RAY DIFFRACTION|2.3|Homo sapiens|0|Transferase/Transferase inhibitor","5UR1|FGFR1 kinase domain complex with SN37333 in reversible binding mode|X-RAY DIFFRACTION|2.2|Homo sapiens|0|transferase/transferase inhibitor","5VND|Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527|X-RAY DIFFRACTION|2.2|Homo sapiens|0|transferase/transferase inhibitor","5W21|Crystal Structure of a 1:1:1 FGF23-FGFR1c-aKlotho Ternary Complex|X-RAY DIFFRACTION|3|Homo sapiens|0|HYDROLASE/PROTEIN BINDING","5W59|Crystal structure of a monomeric human FGF9 in complex with the ectodomain of human FGFR1c|X-RAY DIFFRACTION|2.498|Homo sapiens|0|CYTOKINE","5Z0S|Crystal structure of FGFR1 kinase domain in complex with a novel inhibitor|X-RAY DIFFRACTION|2.45|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5ZV2|FGFR-1 in complex with ligand lenvatinib|X-RAY DIFFRACTION|2.86|Homo sapiens|0|TRANSFERASE","6C18|FGFR1 kinase complex with inhibitor SN37115|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6C19|FGFR1 kinase complex with inhibitor SN36985|X-RAY DIFFRACTION|2.12|Homo sapiens|0|Transferase/Transferase inhibitor","6C1B|FGFR1 kinase complex with inhibitor SN37118|X-RAY DIFFRACTION|2|Homo sapiens|0|Transferase/Transferase inhibitor","6C1C|FGFR1 kinase complex with inhibitor SN37116|X-RAY DIFFRACTION|2.15|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6C1O|FGFR1 kinase domain complexed with FIIN-1|X-RAY DIFFRACTION|2.29|Homo sapiens|0|Transferase/Transferase inhibitor","6ITJ|Crystal structure of FGFR1 kinase domain in complex with compound 3|X-RAY DIFFRACTION|1.994|Homo sapiens|0|TRANSFERASE/INHIBITOR","6MZQ|TAS-120 in reversible binding mode with FGFR1|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE/TRANSFERASE Inhibitor","6MZW|TAS-120 covalent complex with FGFR1|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE/Transferase Inhibitor","6NVL|FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE/TRANSFERASE Inhibitor","6P68|Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE","6P69|Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","7OZB|FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.|X-RAY DIFFRACTION|1.71|Homo sapiens|0|TRANSFERASE","7OZD|FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.|X-RAY DIFFRACTION|1.82|Homo sapiens|0|TRANSFERASE","7OZF|FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 19.|X-RAY DIFFRACTION|1.82|Homo sapiens|0|TRANSFERASE","7TNH|Crystal structure of CSF1R kinase domain in complex with DP-6233|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE","7WCL|Crystal structure of FGFR1 kinase domain with Pemigatinib|X-RAY DIFFRACTION|2.495|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","7YSH|Cryo-EM Structure of FGF23-FGFR1c-aKlotho-HS Quaternary Complex|ELECTRON MICROSCOPY|2.74|Homo sapiens|0|SIGNALING PROTEIN","8JMZ|FGFR1 kinase domain with sulfatinib|X-RAY DIFFRACTION|1.988|Homo sapiens|0|TRANSFERASE/INHIBITOR","8JQI|Cryo EM map of full length PLC gamma 2 and FGFR1 Kinase Domain|ELECTRON MICROSCOPY|4.1|Homo sapiens|0|HYDROLASE","8XLO|FGFR1 kinase domain with a dual-warhead covalent inhibitor CXF-007|X-RAY DIFFRACTION|2.36|Homo sapiens|0|TRANSFERASE/INHIBITOR","8XZ7|FGFR1 kinase domain with a covalent inhibitor 10h|X-RAY DIFFRACTION|1.75|Homo sapiens|0|TRANSFERASE","8Y22|FGFR1 kinase domain with a covalent inhibitor 9g|X-RAY DIFFRACTION|2.792|Homo sapiens|0|TRANSFERASE","8YKI|FGFR-1 in complex with ligand tasurgratinib|X-RAY DIFFRACTION|2.79|Homo sapiens|0|TRANSFERASE","9CD5|FGFR1 Kinase Domain Soak with Inhibitor TYRA-300|X-RAY DIFFRACTION|2.939|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","9UHC|FGFR1 kinase domain with a covalent inhibitor 9p|X-RAY DIFFRACTION|1.88|Homo sapiens|0|TRANSFERASE","9UHI|FGFR1 kinase domain with a covalent inhibitor 9o|X-RAY DIFFRACTION|1.76|Homo sapiens|0|TRANSFERASE"]}]}